Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study.

Claire E ThomasDouglas C BauerJian-Min YuanJane A Cauley

Published in: Cancer causes & control : CCC (2022)

IL-10, an anti-inflammatory cytokine, was associated with lower risk of PCa. Further research of IL-10 and inflammation in relation to PCa development is warranted.

Keyphrases

prostate cancer
anti inflammatory
middle aged
oxidative stress
radical prostatectomy